-
Mashup Score: 1Resumen del ensayo clínico - Resilience H2020 - 12 month(s) ago
RESILIENCE es un ensayo clínico aleatorizado multicéntrico, prospectivo, aleatorizado, de fase II, doble ciego, controlado con placebo para evaluar la
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Chronic pain in oncology patients - Resilience H2020 - 1 year(s) ago
Pain is a symptom that accompanies many cancer patients. Managing it in an appropriate and individualized way is essential to promote the well-being of the
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Dr. Raúl Córdoba: "We can no longer do medicine as we did 10-20 years ago. Things have changed a lot” - Resilience H2020 - 1 year(s) ago
Thanks to the advances we have made, especially in the last decade, in new treatment options for cancer patients, we have managed to increase survival in many
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1The Challenge - Resilience H2020 - 1 year(s) ago
According to the WHO, the incidence of cancer is expected to rise by about 70% over the next 20 years. Half of those diagnosed with cancer will survive for
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1The Therapy - Resilience H2020 - 1 year(s) ago
Remote Ischemic Conditioning is a phenomenon by which brief, reversible episodes of occlusion and re-occlusion in one organ (e.g. an arm) render remote organs
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Resilience H2020 - Home - 2 year(s) ago
Cancer survivors are at high risk for cardiovascular complications. RESILIENCE counts on a multidisciplinary consortium with the active participation of patients.
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Home - Resilience H2020 - 2 year(s) ago
Cancer survivors are at high risk for cardiovascular complications. Anthracyclines are an extremely effective treatment against many cancer types, but they
Source: Resilience H2020Categories: Hem/Oncs, Latest HeadlinesTweet
En #Hematología @Hospital_FJD participamos en el ensayo clínico #RESILIENCE para evaluar los beneficios del condicionamiento isquémico remoto en pacientes con #linfoma no Hodgkin que reciben #antraciclinas. Para saber más 👉 https://t.co/HQNP22tH4k https://t.co/wMtXEr1ooD